« Back
Home /
Infliximab (anti-TNF-alpha)

Infliximab (anti-TNF-alpha)

Item no.	A2019-1mg
Manufacturer	Selleckchem
CASRN	170277-31-3
Amount	1mg
Quantity options	1mg 1mg x 25 1mg x 5
Category	Oncology Neuroscience Neuroinflammation Metabolism Diabetes By Cell Type Cell Biology Obesity Cell Culture Cytokines Cell Status Necrosis Apoptosis Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Remicade, Remsima, Inflectra
Available
Manufacturer - Targets	TNF-alpha
Storage Conditions	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Information	Infliximab (anti-TNF-alpha) is a purified, recombinant DNA-derived chimeric human-mouse IgG monoclonal antibody that consists of mouse heavy and light chain variable regions combined with human heavy and light chain constant regions. Infliximab neutralizes the biological activity of TNF-α by binding with high affinity to the soluble and transmembrane forms of TNF-α, and inhibits or prevents the effective binding of TNF-α with its receptors. MW=144.2 kDa.
Pathway	Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1mg

available

Delivery expected until 1/10/2025

Express Delivery: Save 2 days

Compare

Add to wishlist

Recommend by mail